Comparison between Glenmark Life Sciences IPO and Rolex Rings IPO.
Glenmark Life Sciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rolex Rings IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Rolex Rings IPO is up to ₹731.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Rolex Rings IPO is ₹900.00 per share.
| Glenmark Life Sciences IPO | Rolex Rings IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹695.00 per share | ₹880.00 per share |
| Issue Price (Upper) | ₹720.00 per share | ₹900.00 per share |
| Issue Price (Final) | ₹720.00 per share | ₹900.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 20 shares | 16 shares |
| Fresh Issue Size | 1,47,22,222 shares | 6,22,222 shares |
| Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹56.00 Cr |
| OFS Issue Size | 63,00,000 shares | 75,00,000 shares |
| OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹675.00 Cr |
| Issue Size Total | 2,10,22,222 shares | 81,22,222 shares |
| Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹731.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Rolex Rings IPO opens on Jul 28, 2021. The closing date of Glenmark Life Sciences IPO and Rolex Rings IPO is Jul 29, 2021, and Jul 30, 2021, respectively.
| Glenmark Life Sciences IPO | Rolex Rings IPO | |
|---|---|---|
| Anchor Bid Date | Jul 26, 2021 | Jul 27, 2021 |
| Issue Open | Jul 27, 2021 | Jul 28, 2021 |
| Issue Close | Jul 29, 2021 | Jul 30, 2021 |
| Basis Of Allotment (Tentative) | Aug 03, 2021 | Aug 04, 2021 |
| Initiation of Refunds (Tentative) | Aug 04, 2021 | Aug 05, 2021 |
| Credit of Share (Tentative) | Aug 05, 2021 | Aug 06, 2021 |
| Listing date (Tentative) | Aug 06, 2021 | Aug 09, 2021 |
| Anchor Lockin End date 1 | Sep 02, 2021 | Sep 03, 2021 |
| Anchor Lockin End date 2 | Nov 01, 2021 | Nov 02, 2021 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Rolex Rings IPO P/E ratio of .
| Glenmark Life Sciences IPO | Rolex Rings IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 58.99 | ||||
| Promoter Shareholding (Post-Issue) | 82.84 | 57.64 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8821.96 Cr. | ₹2451.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Glenmark Life Sciences IPO Retail Individual Investors (RII) are offered 73,57,778 shares while in Rolex Rings IPO retail investors are offered 73,57,778 shares. Qualified Institutional Buyers (QIB) are offered 42,04,450 shares in Glenmark Life Sciences IPO and 16,24,444 shares in Rolex Rings IPO.
| Glenmark Life Sciences IPO | Rolex Rings IPO | |
|---|---|---|
| Anchor Investor Reservation | 63,06,660 shares | 24,36,666 shares |
| Market Maker Reservation | ||
| QIB | 42,04,450 shares | 16,24,444 shares |
| NII | 31,53,334 shares | 12,18,334 shares |
| RII | 73,57,778 shares | 28,42,778 shares |
| Employee | ||
| Others | ||
| Total | 2,10,22,222 shares | 81,22,222 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Rolex Rings IPO subscribed 130.44x.
| Glenmark Life Sciences IPO | Rolex Rings IPO | |
|---|---|---|
| QIB (times) | 36.97x | 143.58x |
| NII (times) | 122.54x | 360.11x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 14.63x | 24.49x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 44.17x | 130.44x |
